Effects of T3Rα1 and T3Rα2 gene deletion on T and B lymphocyte development

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 152-160

  Arpin, Christophe ^a   Pihlgren, Maria ^a   Fraichard, Alexandre ^a   Aubert, Denise ^a   Samarut, Jacques ^a   Chassande, Olivier ^a   Marvel, Jacqueline ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CD45 ANTIGEN; CELL NUCLEUS RECEPTOR; GENE PRODUCT; IMMUNOGLOBULIN M; LIOTHYRONINE RECEPTOR; THYROID HORMONE; THYROID HORMONE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL COUNT; CELL MATURATION; CONTROLLED STUDY; FEMALE; GENE DELETION; GRANULOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

EID: 0033976047     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.152     Document Type: Article

References (60)

1. Fabris, N., E. Mocchegiani, and M. Provinciali. 1995. Pituitary-thyroid axis and immune system: a reciprocal neuroendocrine-immune interaction. Horm. Res. 43:29.
2. Rollins-Smith, L. A., A. T. Davis, and P. J. Blair. 1993. Effects of thyroid hormone deprivation on immunity in postmetamorphic frogs. Dev. Comp. Immunol. 17:157.
3. Marsh, J. A., and C. G. Scanes. 1994. Neuroendocrine-immune interactions. Poult. Sci. 73:1049.
4. Villa-Verde, D. M., V. de Mello-Coelho, D. A. Farias-de-Oliveira, M. Dardenne, and W. Savino. 1993. Pleiotropic influence of triiodothyronine on thymus physiology. Endocrinology 133:867.
5. Li, S., E. B. d. Crenshaw, E. J. Rawson, D. M. Simmons, L. W. Swanson, and M. G. Rosenfeld. 1990. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347:528.
6. Van Buul-Offers, S. C., R. J. Bloemen, M. G. Reijnen-Gresnigt, H. A. van Leiden, C. M. Hoogerbrugge, and J. L. Van den Brande. 1994. Insulin-like growth factors-I and -II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy. J. Endocrinol. 143:191.
7. Fabris, N., W. Pierpaoli, and E. Sorkin. 1971. Hormones and the immunological capacity. III. The immunodeficiency disease of the hypopituitary Snell-Bagg dwarf mouse. Clin. Exp. Immunol. 9:209.
8. Fabris, N., W. Pierpaoli, and E. Sorkin. 1971. Hormones and the immunological capacity. IV. Restorative effects of developmental hormones or of lymphocytes on the immunodeficiency syndrome of the dwarf mouse. Clin. Exp. Immunol. 9:227.
9. Duquesnoy, R., and G. Pederson. 1981. Immunologic and hematologic deficiencies of the hypopituitary dwarf mouse. In Immunological Defects in Laboratory Animals, Vol. 1. M. Gershwin and B. Merchant, eds. Plenum Press, New York, p. 309.
10. Murphy, W. J., S. K. Durum, M. R. Anver, and D. L. Longo. 1992. Immunologic and hematologic effects of neuroendocrine hormones: studies on DW/J dwarf mice. J. Immunol. 148:3799.
11. Murphy, W. J., S. K. Durum, and D. L. Longo. 1993. Differential effects of growth hormone and prolactin on murine T cell development and function. J. Exp. Med. 178:231.
12. Montecino-Rodriguez, E., R. Clark, A. Johnson, L. Collins, and K. Dorshkind. 1996. Defective B cell development in Snell dwarf (dw/dw) mice can be corrected by thyroxine treatment. J. Immunol. 157:3334.
13. Montecino-Rodriguez, E., R. G. Clark, L. Powell-Braxton, and K. Dorshkind. 1997. Primary B cell development is impaired in mice with defects of the pituitary/thyroid axis. J. Immunol. 159:2712.
14. Horseman, N. D., W. Zhao, E. Montecino-Rodriguez, M. Tanaka, K. Nakashima, S. J. Engle, F. Smith, E. Markoff, and K. Dorshkind. 1997. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 16:6926.
15. Berry, M. J., and P. R. Larsen. 1992. The role of selenium in thyroid hormone action. Endocr. Rev. 13:207.
16. St. Germain, D. L., and V. A. Galton. 1997. The deiodinase family of seleno-proteins. Thyroid 7:655.
17. Lazar, M. A. 1993. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr. Rev. 14:184.
18. Hsu, J.-H., and G. Brent. 1998. Thyroid hormone receptor gene knockouts. Trends Endocrinol. Metab. 9:103.
19. Fraichard, A., O. Chassande, M. Plateroti, J. P. Roux, J. Trouillas, C. Dehay, C. Legrand, K. Gauthier, M. Kedinger, L. Malaval, B. Rousset, and J. Samarut. 1997. The T3R α gene encoding a thyroid hormone receptor is essential for postnatal development and thyroid hormone production. EMBO J. 16:4412.
20. Forrest, D., E. Hanebuth, R. J. Smeyne, N. Everds, C. L. Stewart, J. M. Wehner, and T. Curran. 1996. Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor β: evidence for tissue-specific modulation of receptor function. EMBO J. 15:3006.
21. Wikstrom, L., C. Johansson, C. Salto, C. Barlow, A. Campos Barros, F. Baas, D. Forrest, P. Thoren, and B. Vennstrom. 1998. Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor α1. EMBO J. 17:455.
22. Chassande, O., A. Fraichard, K. Gauthier, F. Flamant, C. Legrand, P. Savatier, V. Laudet, and J. Samarut. 1997. Identification of transcripts initiated from an internal promoter in the c-erbA α locus that encode inhibitors of retinoic acid receptor-α and triiodothyronine receptor activities. Mol. Endocrinol. 11:1278.
23. + T cells are hyperreactive to antigenic challenge in vitro. J. Exp. Med. 184:2141.
24. Nagy, A., and J. Rossant. 1993. Production of completely ES cell-derived fetuses. In Gene Targeting: A Practical Approach. A. Joyner, ed. IRL Press, Oxford University Press, Oxford.
25. Wilder, R. L. 1995. Neuroendocrine-immune system interactions and autoimmunity. Annu. Rev. Immunol. 13:307.
26. Gruber, J., R. Sgonc, Y. H. Hu, H. Beug, and G. Wick. 1994. Thymocyte apoptosis induced by elevated endogenous corticosterone levels. Eur. J. Immunol. 24:1115.
27. Cross, R. J., J. S. Bryson, and T. L. Roszman. 1992. Immunologic disparity in the hypopituitary dwarf mouse. J. Immunol. 148:1347.
28. Rolink, A., U. Grawunder, T. H. Winkler, H. Karasutama, and F. Melchers. 1994. IL-2 receptor α chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int. Immunol. 6:1257.
29. Osmond, D. G. 1986. Population dynamics of bone marrow B lymphocytes. Immunol. Rev. 93:103.
30. Osmond, D. G. 1990. B cell development in the bone marrow. Semin. Immunol. 2:173.
31. Forrest, D., M. Sjoberg, and B. Vennstrom. 1990. Contrasting developmental and tissue-specific expression of α and β thyroid hormone receptor genes. EMBO J. 9:1519.
32. Schwartz, H. L., K. A. Strait, N. C. Ling, and J. H. Oppenheimer. 1992. Quantitation of rat tissue thyroid hormone binding receptor isoforms by immunoprecipitation of nuclear triiodothyronine binding capacity. J. Biol. Chem. 267:11794.
33. Schatz, D. G., M. A. Oettinger, and D. Baltimore. 1989. The V(D)J recombination activating gene. RAG-I. Cell 59:1035.
34. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAG-I-deficient mice have no mature B and T lymphocytes. Cell 68:869.
35. Osmond, D. G., S. Rico-Vargas, H. Valenzona, L. Fauteux, L. Liu, R. Janani, L. Lu, and K. Jacobsen. 1994. Apoptosis and macrophage-mediated cell deletion in the regulation of B lymphopoiesis in mouse bone marrow. Immunol. Rev. 142:209.
36. Evans, R. M., N. C. Birnberg, and M. G. Rosenfeld. 1982. Glucocorticoid and thyroid hormones transcriptionally regulate growth hormone gene expression. Proc. Natl. Acad. Sci. USA 79:7659.
37. Landreth, K. S., R. Narayanan, and K. Dorshkind. 1992. Insulin-like growth factor-I regulates pro-B cell differentiation. Blood 80:1207.
38. Gibson, L. F., D. Piktel, and K. S. Landreth. 1993. Insulin-like growth factor-I potentiates expansion of interleukin-7-dependent pro-B cells. Blood 82:3005.
39. Hastings, M. L., C. Milcarek, K. Martincic, M. L. Peterson, and S. H. Munroe. 1997. Expression of the thyroid hormone receptor gene, erbAα, in B lymphocytes: alternative mRNA processing is independent of differentiation but correlates with antisense RNA levels. Nucleic Acids Res. 25:4296.
40. Weigent, D. A., J. B. Baxter, and J. E. Blalock. 1992. The production of growth hormone and insulin-like growth factor-I by the same subpopulation of rat mononuclear leukocytes. Brain Behav. Immun. 6:365.
41. Geffner, M. 1997. Effects of growth hormone and insulin-like growth factor I on T- and B-lymphocytes and immune function. Acta Paediatr. Suppl. 423:76.
42. Clark, R., J. Strasser, S. McCabe, K. Robbins, and P. Jardieu. 1993. Insulin-like growth factor-I stimulation of lymphopoiesis. J. Clin. Invest. 92:540.
43. Murphy, W. J., S. K. Durum, and D. L. Longo. 1992. Role of neuroendocrine hormones in murine T cell development: growth hormone exerts thymopoietic effects in vivo. J. Immunol. 149:3851.
44. Savino, W., V. de Mello-Coelho, and M. Dardenne. 1995. Control of the thymic microenvironment by growth hormone/insulin-like growth factor-I-mediated circuits. Neuroimmunomodulation 2:313.
45. Bach, J. F., M. Dardenne, J. M. Pleau, and M. A. Bach. 1975. Isolation, biochemical characteristics, and biological activity of a circulating thymic hormone in the mouse and in the human. Ann. NY Acad. Sci. 249:186.
46. Fabris, N., and E. Mocchegiani. 1985. Endocrine control of thymic serum factor production in young-adult and old mice. Cell. Immunol. 91:325.
47. Fabris, N., E. Mocchegiani, S. Mariotti, F. Pacini, and A. Pinchera. 1986. Thyroid function modulates thymic endocrine activity. J. Clin. Endocrinol. Metab. 62: 474.
48. Costa Rosa, L. F. B. P., Y. Cury, and R. Curi. 1992. Effects of insulin, glucocorticoids and thyroid hormones on the activities of key enzymes of glycolysis, glutaminolysis, the pentose-phosphate pathway and the Krebs cycle in rat macrophages. J. Endocrinol. 135:213.
49. Pereira, B., L. F. Rosa, D. A. Safi, E. J. Bechara, and R. Curi. 1995. Hormonal regulation of superoxide dismutase, catalase, and glutathione peroxidase activities in rat macrophages. Biochem. Pharmacol. 50:2093.
50. Balazs, C., A. Leovey, M. Szabo, and G. Bako. 1980. Stimulating effect of triiodothyronine on cell-mediated immunity. Eur. J. Clin. Pharmacol. 17:19.
51. Komorowski, J., H. Stepien, and M. Pawlikowski. 1993. The evidence of thyroliberin/triiodothyronine control of TSH secretory response from human peripheral blood monocytes cultured in vitro. Neuropeptides 25:31.
52. Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, et al. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835.
53. Mangelsdorf, D. J., and R. M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83:841.
54. Brent, G. A., D. D. Moore, and P. R. Larsen. 1991. Thyroid hormone regulation of gene expression. Annu. Rev. Physiol. 53:17.
55. Glass, C. K. 1994. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr. Rev. 15:391.
56. Koenig, R. J., M. A. Lazar, R. A. Hodin, G. A. Brent, P. R. Larsen, W. W. Chin, and D. D. Moore. 1989. Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing. Nature 337:659.
57. Weiss, R. E., D. Forrest, J. Pohlenz, K. Cua, T. Curran, and S. Refetoff. 1997. Thyrotropin regulation by thyroid hormone in thyroid hormone receptor β-deficient mice. Endocrinology 138:3624.
58. Plateroti, M., O. Chassande, A. Fraichard, K. Gauthier, J.-N. Freund, J. Samarut, and M. Kedinger. 1999. Involvement of T3Rα- and β-receptor subtypes in mediating T3 functions during postnatal murine intestinal development. Gastroenterology 116:1367.
59. Gao, F. B., J. Apperly, and M. Raff. 1998. Cell-intrinsic timers and thyroid hormone regulate the probability of cell-cycle withdrawal and differentiation of oligodendrocyte precursor cells. Dev. Biol. 197:54.
60. Brucker-Davis, F., M. C. Skarulis, M. B. Grace, J. Benichou, P. Hauser, E. Wiggs, and B. D. Weintraub. 1995. Genetic and clinical features of 42 kindreds with resistance to thyroid hormone: The National Institutes of Health Prospective Study. Ann. Intern. Med. 123:572.